SOCIAL-INTERACTION AND ELEVATED PLUS-MAZE TESTS - CHANGES IN RELEASE AND UPTAKE OF 5-HT AND GABA

被引:72
|
作者
FILE, SE
ZANGROSSI, H
ANDREWS, N
机构
[1] Psychopharmacology Research Unit, UMDS Division of Pharmacology, Guy's Hospital, London
基金
英国惠康基金;
关键词
ANXIETY; 5-HT; GABA; HIPPOCAMPUS; CORTEX; RELEASE; UPTAKE;
D O I
10.1016/0028-3908(93)90103-A
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Changes in release and uptake of [H-3]5-HT and [C-14]GABA were compared in slices taken from the hippocampus and frontal cortex of rats, left undisturbed in their home-cages, or exposed for 5 min to the elevated plus-maze or social interaction tests of anxiety. Exposure to the plus-maze decreased cortical GABA function (shown by decreased release) and increased hippocampal 5-HT function (shown by increased K+-evoked release but more markedly by decreased uptake). Compared with undisturbed home cage controls, only the high light, familiar condition of the social interaction test resulted in a significant increase in K+-evoked release of both [H-3]5-HT and [C-14]GABA from the hippocampus. All four social interaction test conditions resulted in increases in cortical uptake of [H-3]5-HT and all but the high fight, unfamiliar condition increased cortical uptake of [C-14]GABA. Analysing the two factors manipulated in the social interaction test, unfamiliarity with the test arena resulted in increased uptake of hippocampal [H-3]5-HT and decreased cortical [C-14]GABA, whereas an increase in the level of light decreased the cortical uptake of [C-14]GABA. The results show that changes in presynaptic function occur rapidly in response to a brief exposure to animal tests of anxiety. However, only the increased hippocampal release of 5-HT is likely to be causally linked to anxiety and the results show that this cannot be the sole explanation.
引用
收藏
页码:217 / 221
页数:5
相关论文
共 50 条
  • [11] EFFECTS OF BOC-CCK-4 AND L365.260 ON CORTICAL 5-HT RELEASE IN GUINEA-PIGS ON EXPOSURE TO THE ELEVATED PLUS-MAZE
    REX, A
    FINK, H
    MARSDEN, CA
    NEUROPHARMACOLOGY, 1994, 33 (3-4) : 559 - 565
  • [12] Use of the elevated plus-maze and social interaction tests as rodent models of anxiety: Ontogeny, pitfalls and lessons learned
    Doremus-Fitzwater, Tamara L.
    Varlinskaya, Elena I.
    Spear, Linda P.
    NEUROTOXICOLOGY AND TERATOLOGY, 2006, 28 (06) : 706 - 707
  • [13] EFFECT OF DIAZEPAM ON CORTICAL 5-HT RELEASE AND BEHAVIOR IN THE GUINEA-PIG ON EXPOSURE TO THE ELEVATED PLUS MAZE
    REX, A
    MARSDEN, CA
    FINK, H
    PSYCHOPHARMACOLOGY, 1993, 110 (04) : 490 - 496
  • [14] THE EFFECTS OF 5-HT1B CHARACTERIZING AGENTS IN THE MOUSE ELEVATED PLUS-MAZE
    BENJAMIN, D
    LAL, H
    MEYERSON, LR
    LIFE SCIENCES, 1990, 47 (03) : 195 - 203
  • [15] COMPARISON OF ANXIETY MEASURED IN THE ELEVATED PLUS-MAZE, OPEN-FIELD AND SOCIAL-INTERACTION TESTS BETWEEN SPONTANEOUSLY HYPERTENSIVE RATS AND WISTAR EPM-1 RATS
    GOTO, SH
    CONCEICAO, IM
    RIBEIRO, RA
    FRUSSAFILHO, R
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1993, 26 (09) : 965 - 969
  • [16] SOCIAL-INTERACTION INCREASES 5-HT RELEASE AND CAMP EFFLUX IN THE RAT VENTRAL HIPPOCAMPUS IN-VIVO
    CADOGAN, AK
    KENDALL, DA
    FINK, H
    MARSDEN, CA
    BEHAVIOURAL PHARMACOLOGY, 1994, 5 (03): : 299 - 305
  • [17] MIANSERIN-INDUCED 5-HT(2) RECEPTOR DOWN-REGULATION RESULTS IN ANXIOLYTIC EFFECTS IN THE ELEVATED PLUS-MAZE TEST
    BENJAMIN, D
    SAIFF, EI
    NEVINS, T
    LAL, H
    DRUG DEVELOPMENT RESEARCH, 1992, 26 (03) : 287 - 297
  • [18] Involvement of 5-HT1D receptors in cortical extracellular 5-HT release in guinea-pigs on exposure to the elevated plus maze
    Rex, A
    Fink, H
    Skingle, M
    Marsden, CA
    JOURNAL OF PSYCHOPHARMACOLOGY, 1996, 10 (03) : 219 - 224
  • [19] Effects of 5-HT4 receptor antagonists on rat behaviour in the elevated plus-maze test
    Silvestre, JS
    Fernandez, AG
    Palacios, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (03) : 219 - 222
  • [20] NOVEL ENVIRONMENT AND CAT ODOR CHANGE GABA AND 5-HT RELEASE AND UPTAKE IN THE RAT
    FILE, SE
    ZANGROSSI, H
    ANDREWS, N
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 45 (04) : 931 - 934